Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein
- PMID: 1500863
- PMCID: PMC2119319
- DOI: 10.1084/jem.176.2.623
Inhibition of tumor growth in vivo with a soluble CD44-immunoglobulin fusion protein
Abstract
CD44H is the principal cell surface receptor for hyaluronate, which is a major glycosaminoglycan of the extracellular matrix. Expression of CD44H is enhanced in a variety of malignant tumors and correlates with tumor aggressiveness, supporting the notion that interaction between CD44H and hyaluronate may play an important role in tumor growth and dissemination. In this report we show that in vivo tumor formation by human lymphoma Namalwa cells, stably transfected with CD44H, can be suppressed by a soluble human CD44H-immunoglobulin fusion protein. Disruption of the interaction between CD44H and its physiologic ligands may provide a novel strategy for controlling tumor growth in vivo.
Similar articles
-
CD44H regulates tumor cell migration on hyaluronate-coated substrate.J Cell Biol. 1992 Aug;118(4):971-7. doi: 10.1083/jcb.118.4.971. J Cell Biol. 1992. PMID: 1380003 Free PMC article.
-
Distinct effects of two CD44 isoforms on tumor growth in vivo.J Exp Med. 1991 Oct 1;174(4):859-66. doi: 10.1084/jem.174.4.859. J Exp Med. 1991. PMID: 1919439 Free PMC article.
-
Regulation of human CD44H and CD44E isoform binding to hyaluronan by phorbol myristate acetate and anti-CD44 monoclonal and polyclonal antibodies.J Immunol. 1993 Dec 1;151(11):6490-9. J Immunol. 1993. PMID: 7504022
-
[CD44, the hyaluronic acid cell receptor. Its role in neoplastic invasion and metastatic dissemination].Bull Cancer. 1993 Oct;80(10):833-44. Bull Cancer. 1993. PMID: 7515731 Review. French.
-
CD44 splice variants: metastases meet lymphocytes.Immunol Today. 1993 Aug;14(8):395-9. doi: 10.1016/0167-5699(93)90141-7. Immunol Today. 1993. PMID: 7691067 Review.
Cited by
-
Proteoglycans in Normal and Healing Skin.Adv Wound Care (New Rochelle). 2015 Mar 1;4(3):152-173. doi: 10.1089/wound.2013.0464. Adv Wound Care (New Rochelle). 2015. PMID: 25785238 Free PMC article.
-
Human ovarian tumour cells can bind hyaluronic acid via membrane CD44: a possible step in peritoneal metastasis.Clin Exp Metastasis. 1996 Sep;14(4):325-34. doi: 10.1007/BF00123391. Clin Exp Metastasis. 1996. PMID: 8878406
-
LYVE-1, a new homologue of the CD44 glycoprotein, is a lymph-specific receptor for hyaluronan.J Cell Biol. 1999 Feb 22;144(4):789-801. doi: 10.1083/jcb.144.4.789. J Cell Biol. 1999. PMID: 10037799 Free PMC article.
-
Targeted disruption of CD44 in MDAY-D2 lymphosarcoma cells has no effect on subcutaneous growth or metastatic capacity.J Cell Biol. 1995 Dec;131(6 Pt 2):1849-55. doi: 10.1083/jcb.131.6.1849. J Cell Biol. 1995. PMID: 8557751 Free PMC article.
-
Soluble hyaluronan receptor RHAMM induces mitotic arrest by suppressing Cdc2 and cyclin B1 expression.J Exp Med. 1996 Apr 1;183(4):1663-8. doi: 10.1084/jem.183.4.1663. J Exp Med. 1996. PMID: 8666924 Free PMC article.
References
Publication types
MeSH terms
Substances
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical
Miscellaneous